Resultados de la búsqueda 21-30 of 8081 for ✏[광고텔레:TOOPPC] 웹문서작업업체 개인통장업체 백링크광고 상위노출광고 구글1페이지광고 카지노알광고 언더키워드대행 법인장구매 카지노커뮤니티 구글휴게텔홍보✏
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...
- No evidence of metastatic disease. Lymphadenopathy (defined as nodes measuring >1 cm in short axis) outside the surgical basin (i.e., para-aortic, peri-caval, ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
... 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy. Study of Tumor-treating Fields to Treat Leptomeningeal Metastases from Breast Carcinoma ...
The study will include a Phase 1 part to determine the recommended dose of JCAR017 monotherapy in subjects with relapsed or refractory CLL or SLL, followed by a ...
... (1) anti-CTLA-4 +/- anti-PD-1/PD-L1, and (2) anti-PD-1/PD-L1 +/- chemo. Secondary Goals. To evaluate the safety of multi-strain probiotic blend in cancer ...
In Part 2, the step-up dose identified in Part 1 will be used followed by the target dose of ABBV-383. Inotuzumab Ozogamicin and Post-Induction Chemotherapy in ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
The aim of this study is to create a patient and patient-advocate catalyzed tumor bank for the retrieval, processing, analysis, and maintenance of ...
The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?